Walgreens Boots Alliance (WBA)
(Delayed Data from NSDQ)
$8.74 USD
+0.09 (1.04%)
Updated Sep 5, 2024 04:00 PM ET
Pre-Market: $8.71 -0.03 (-0.34%) 8:28 AM ET
5-Strong Sell of 5 5
D Value D Growth A Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$8.74 USD
+0.09 (1.04%)
Updated Sep 5, 2024 04:00 PM ET
Pre-Market: $8.71 -0.03 (-0.34%) 8:28 AM ET
5-Strong Sell of 5 5
D Value D Growth A Momentum D VGM
Zacks News
Walgreens Boots Alliance (WBA) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed the most recent trading day at $79.76, moving -0.04% from the previous trading session.
Company News For Nov 20, 2018
by Zacks Equity Research
Companies In The News Are: XEC,REN,SPB,WBA,CFX
Zacks Value Trader Highlights: BP, Walgreens, Sony, MetLife and PACCAR
by Zacks Equity Research
Zacks Value Trader Highlights: BP, Walgreens, Sony, MetLife and PACCAR
Walgreens Boots Alliance (WBA) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed the most recent trading day at $82.29, moving +0.94% from the previous trading session.
5 Cheap Large Cap Stocks to Buy Now
by Tracey Ryniec
Don't be scared about the stock market sell off, look for big cap deals instead.
Why Walgreens Boots (WBA) Could Be a Top Value Stock Pick
by Zacks Equity Research
Walgreens Boots (WBA) seems to be a good value pick, as it has decent revenue metrics to back up its earnings, and is seeing solid earnings estimate revisions as well.
Why Is Walgreens (WBA) Up 16.2% Since Last Earnings Report?
by Zacks Equity Research
Walgreens (WBA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Is Walgreens Boots Alliance (WBA) Stock Outpacing Its Retail-Wholesale Peers This Year?
by Zacks Equity Research
Is (WBA) Outperforming Other Retail-Wholesale Stocks This Year?
Walgreens (WBA) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Walgreens (WBA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Walgreens Boots Alliance (WBA) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed the most recent trading day at $81.91, moving +1.63% from the previous trading session.
Walgreens Boots Alliance (WBA) is a Great Momentum Stock: Should You Buy?
by Zacks Equity Research
Does Walgreens Boots Alliance (WBA) have what it takes to be a top stock pick for momentum investors? Let's find out.
What to Expect from CVS Health's Q3 Earnings
by Benjamin Rains
Let's see what to expect from CVS before the opening bell Tuesday.
Should You Buy CVS Stock Ahead of Q3 Earnings?
by Benjamin Rains
Let's see if investors should think about buying CVS stock ahead of its Q3 financial results.
Dow Recovers More Than 900 Points in 3 Days: 5 Top Picks
by Nalak Das
The meltdown of the 30-stock Dow was transitory in nature and can provide a good entry point for investors.
Walgreens Boots Alliance (WBA) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed the most recent trading day at $79.90, moving +0.16% from the previous trading session.
Walgreens Boots Alliance (WBA) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed at $76.23 in the latest trading session, marking a +0.65% move from the prior day.
Is Walgreens Boots Alliance (WBA) Outperforming Other Retail-Wholesale Stocks This Year?
by Zacks Equity Research
Is (WBA) Outperforming Other Retail-Wholesale Stocks This Year?
Walgreens Boots Alliance (WBA) Stock Moves -0.48%: What You Should Know
by Zacks Equity Research
In the latest trading session, Walgreens Boots Alliance (WBA) closed at $76.61, marking a -0.48% move from the previous day.
Walgreens Boots (WBA) Stock Looks Like A Cheap, Solid Buy Right Now
by Benjamin Rains
Shares of Walgreens Boots Alliance (WBA) jumped roughly 1.6% Monday as investors continue to dive in after it posted impressive fiscal fourth-quarter results late last week. Looking ahead, the pharmaceutical giant looks poised for strong growth and WBA stock seems like it might be worth buying right now.
Company News For Oct 12, 2018
by Zacks Equity Research
Companies in the news are: DAL, WBA, COST and CRSP
Dow 30 Stock Roundup: Walgreens' Earnings Top, UTX Board OKs Dividend Hike
by Swarup Gupta
The index suffered a particularly dismal week, weighed down by surging bond yields.
Walgreens (WBA) Q4 Earnings Top Estimates, Revenues Lag
by Zacks Equity Research
Walgreens' (WBA) Retail Pharmacy USA division witnesses comparable prescription growth and benefits from a strong retail prescription market.
Walgreens Boots Alliance (WBA) Q4 Earnings Surpass Estimates
by Zacks Equity Research
Walgreens (WBA) delivered earnings and revenue surprises of 2.78% and -0.59%, respectively, for the quarter ended August 2018. Do the numbers hold clues to what lies ahead for the stock?
Walgreens (WBA) Stock Sinks 1.7% Ahead of Q4 Earnings: What to Watch
by Benjamin Rains
Shares of Walgreens Boots Alliance (WBA) slipped 1.7% during regular trading hours Wednesday in a sign that investors might be a tad bit nervous about the pharmacy and cosmetic giant's Q4 earnings results Thursday.
Stock Market News For Oct 9, 2018
by Zacks Equity Research
Stocks ended mostly lower on Monday as fears of rising interest rates continued to dent investor sentiment